Date | Time | Source | Headline | Symbol | Company |
05/29/2024 | 4:15PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:KNW | Know Labs Inc |
05/16/2024 | 9:00AM | Business Wire | Know Labs Appoints Chris Somogyi as President, International | AMEX:KNW | Know Labs Inc |
05/15/2024 | 4:15PM | Business Wire | Know Labs, Inc. Reports Second Quarter FY 2024 Results | AMEX:KNW | Know Labs Inc |
05/09/2024 | 9:00AM | Business Wire | Know Labs to Present Clinical Research at the 2024 American Association of Clinical Endocrinology Annual Meeting | AMEX:KNW | Know Labs Inc |
05/08/2024 | 9:00AM | Business Wire | Know Labs, Inc. to Host Review of Second Quarter Fiscal Year 2024 Results on May 15, 2024 | AMEX:KNW | Know Labs Inc |
04/05/2024 | 9:00AM | Business Wire | Know Labs to Present Clinical Research at the 2024 American Physiology Summit | AMEX:KNW | Know Labs Inc |
03/06/2024 | 4:15PM | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] | AMEX:KNW | Know Labs Inc |
03/06/2024 | 4:10PM | Edgar (US Regulatory) | Form 8-K - Current report | AMEX:KNW | Know Labs Inc |
03/06/2024 | 9:00AM | Business Wire | Know Labs’ Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research Study | AMEX:KNW | Know Labs Inc |
02/29/2024 | 4:17PM | Edgar (US Regulatory) | Form 8-K - Current report | AMEX:KNW | Know Labs Inc |
02/29/2024 | 4:15PM | Business Wire | Know Labs Secures U.S. $12 Million Funding for Company’s Further Execution on Its Clinical Research and Development Initiatives | AMEX:KNW | Know Labs Inc |
02/27/2024 | 11:44AM | Business Wire | Know Labs Announces the KnowU™, its Wearable Non-Invasive Continuous Glucose Monitor | AMEX:KNW | Know Labs Inc |
02/27/2024 | 9:03AM | Edgar (US Regulatory) | Form 8-K - Current report | AMEX:KNW | Know Labs Inc |
02/27/2024 | 9:00AM | Business Wire | Know Labs Announces the KnowU™, its Wearable Non-Invasive Continuous Glucose Monitor | AMEX:KNW | Know Labs Inc |
02/14/2024 | 4:17PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | AMEX:KNW | Know Labs Inc |
02/14/2024 | 4:15PM | Edgar (US Regulatory) | Form 8-K - Current report | AMEX:KNW | Know Labs Inc |
02/14/2024 | 4:15PM | Business Wire | Know Labs, Inc. Reports First Quarter FY2024 Results | AMEX:KNW | Know Labs Inc |
02/09/2024 | 4:23PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:KNW | Know Labs Inc |
02/09/2024 | 4:22PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:KNW | Know Labs Inc |
02/09/2024 | 4:20PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:KNW | Know Labs Inc |
02/09/2024 | 4:19PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:KNW | Know Labs Inc |
02/09/2024 | 4:18PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:KNW | Know Labs Inc |
02/09/2024 | 4:17PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:KNW | Know Labs Inc |
02/07/2024 | 9:00AM | Business Wire | Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2024 Results on February 14, 2024 | AMEX:KNW | Know Labs Inc |
01/23/2024 | 9:00AM | Business Wire | Know Labs to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) | AMEX:KNW | Know Labs Inc |
01/12/2024 | 12:15AM | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | AMEX:KNW | Know Labs Inc |
01/05/2024 | 4:16PM | Edgar (US Regulatory) | Form S-3/A - Registration statement under Securities Act of 1933: [Amend] | AMEX:KNW | Know Labs Inc |
12/22/2023 | 4:15PM | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of 1933 | AMEX:KNW | Know Labs Inc |
12/19/2023 | 4:15PM | Business Wire | Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results | AMEX:KNW | Know Labs Inc |
12/19/2023 | 4:03PM | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | AMEX:KNW | Know Labs Inc |